As part of its commitment to strengthening regulatory partnerships across Africa, Gennvax held a high-level meeting with the Medicines Control Authority of Zimbabwe (MCAZ), represented by Dr. Zivanai Makoni, Head of the Evaluation and Registration Division.
During this strategic meeting, both parties agreed to initiate a pilot program that positions Egypt and Gennvax as the first collaborators to begin the vaccine registration submission process through the newly established MCAZ online platform.
Gennvax has officially received the first access link to commence the upload of its registration and evaluation files — a significant step toward accelerating the availability of quality-assured vaccines in the Zimbabwean market.
This collaboration reflects Gennvax’s ongoing efforts to enhance regulatory cooperation, streamline vaccine registration processes, and reinforce its role as a trusted African manufacturer committed to supporting health security and innovation across the continent.

“The Egyptian Ambassador to Zimbabwe / Hala Serag El Din and the entire embassy team extended their full support to our national project, reflecting the strong spirit of collaboration and shared commitment between Egypt and Zimbabwe toward advancing health and vaccine self-sufficiency across Africa,” said Gennvax representatives.

NAT Pharm Collaborates with Gennvax on Strategic Initiatives NatT Pharm, the leading procurement partner for Zimbabwean health authorities, along with its Managing Director, Newman B. Madzikwa, has formally agreed to collaborate with Gennvax on this strategic initiative. This partnership underscores a shared commitment to enhancing vaccine access, supporting local health systems, and strengthening regional healthcare capabilities.